ResMed CEO sells 400,000 shares

Wednesday, February 6, 2013

SAN DIEGO – ResMed CEO and Executive Chairman Peter Farrell sold 400,000 shares at an average price of $46.98 on Jan. 30, according to an article from Farrell made the sale the same day CMS announced a reimbursement cut of, on average, 45% as part of Round 2 of competitive bidding, which drove ResMed’s stock price to drop more than 6%.